Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

Download PDF
Federal RegisterJun 9, 2014
79 Fed. Reg. 32961 (Jun. 9, 2014)

The meeting announced below concerns Demonstration Projects on Health Systems Change to Integrate Tobacco Dependence Treatment into Clinical Care and Assessment of Related Outcomes, Special Interest Projects (SIP)14-028; and Applied Research and Development of Tools to Address Point-of-Sale Tobacco Marketing, SIP14-029, Panel B, initial review.

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

Time and Date: 9:00 a.m.-6:00 p.m., June 18, 2014 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to “Demonstration Projects on Health Systems Change to Integrate Tobacco Dependence Treatment into Clinical Care and Assessment of Related Outcomes, SIP14-028; and Applied Research and Development of Tools to Address Point-of-Sale Tobacco Marketing, SIP14-029, Panel B, initial review.”

Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.

This notice is being published on less than 15 days prior to the meeting date because no earlier notification of the meeting was practicable.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

[FR Doc. 2014-13389 Filed 6-6-14; 8:45 am]

BILLING CODE 4163-18-P